Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viavi Solutions (VIAV) Research & Development: 2009-2025

Historic Research & Development for Viavi Solutions (VIAV) over the last 16 years, with Sep 2025 value amounting to $56.0 million.

  • Viavi Solutions' Research & Development rose 13.36% to $56.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $215.3 million, marking a year-over-year increase of 6.90%. This contributed to the annual value of $208.7 million for FY2025, which is 3.37% up from last year.
  • Latest data reveals that Viavi Solutions reported Research & Development of $56.0 million as of Q3 2025, which was down 2.10% from $57.2 million recorded in Q2 2025.
  • Viavi Solutions' 5-year Research & Development high stood at $57.2 million for Q2 2025, and its period low was $49.4 million during Q3 2024.
  • In the last 3 years, Viavi Solutions' Research & Development had a median value of $50.8 million in 2023 and averaged $51.7 million.
  • Its Research & Development has fluctuated over the past 5 years, first climbed by 15.78% in 2021, then decreased by 7.47% in 2023.
  • Over the past 5 years, Viavi Solutions' Research & Development (Quarterly) stood at $53.6 million in 2021, then climbed by 2.77% to $51.9 million in 2022, then decreased by 4.62% to $49.5 million in 2023, then grew by 5.25% to $52.1 million in 2024, then rose by 13.36% to $56.0 million in 2025.
  • Its Research & Development stands at $56.0 million for Q3 2025, versus $57.2 million for Q2 2025 and $50.0 million for Q1 2025.